First Light Asset Management’s Krystal Biotech KRYS Stock Holding History

First Light Asset Management’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-101,259	Closed	-$11.9M	–	77
2023 Q2	$11.9M	Sell	101,259 -94,721	-48%	-$9.67M	0.93%	35
2023 Q1	$15.7M	Sell	195,980 -277,711	-59%	-$21.8M	1.41%	24
2022 Q4	$37.5M	Sell	473,691 -18,864	-4%	-$1.4M	3.48%	7
2022 Q3	$34.3M	Sell	492,555 -103,057	-17%	-$7.45M	3.47%	10
2022 Q2	$39.1M	Sell	595,612 -122,324	-17%	-$7.61M	4.55%	7
2022 Q1	$47.8M	Buy	717,936 +37,766	+6%	+$2.36M	4.21%	8
2021 Q4	$47.6M	Buy	680,170 +46,689	+7%	+$2.72M	3.41%	10
2021 Q3	$33.1M	Buy	633,481 +106,831	+20%	+$6.32M	2.18%	20
2021 Q2	$35.8M	Buy	526,650 +35,139	+7%	+$2.45M	2.15%	20
2021 Q1	$37.9M	Sell	491,511 -229	-0%	-$16.6K	2.51%	16
2020 Q4	$29.5M	Buy	491,740 +27,077	+6%	+$1.35M	2.18%	17
2020 Q3	$20M	Buy	464,663 +484	+0.1%	+$21K	2.05%	17
2020 Q2	$19.2M	Buy	+464,179	New	+$22.3M	2.24%	16

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Light Asset Management's KRYS Position: Q3 2023 in Review

First Light Asset Management sold out of Krystal Biotech (KRYS) in Q3 2023, closing a stake of 101,259 shares — an estimated $11.9M sold.

First Light Asset Management first reported a position in KRYS in Q2 2020 and held it in 13 quarters. The position peaked at $47.8M in Q1 2022. 188 funds tracked by Wall St. Rank hold KRYS as of Q3 2023.

First Light Asset Management reported no remaining Krystal Biotech position as of Q3 2023 after selling out during the quarter.
First Light Asset Management sold 101,259 Krystal Biotech shares in Q3 2023, an estimated $11.9M.
First Light Asset Management first reported a position in Krystal Biotech in Q2 2020 and held it in 13 quarters.
First Light Asset Management's Krystal Biotech position peaked at $47.8M in Q1 2022.
188 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2023.

Based on First Light Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.